What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers’ and Patients’ Perceptions of, and Experiences with, Generic Medicines
- 218 Downloads
Background and Objective
Considerable emphasis is placed on the use of generic medicines because of the potential economic benefits associated with their use. The objective of this systematic review is to compile and collate published research regarding patient/consumer perceptions and attitudes in relation to generic medicines, aiming to describe such views and detail patient experiences with generic medicines.
Literature published between 2005 and July 2015, indexed in PubMed, Scopus and EMBASE, on the topic of consumer or patient opinions of generic medicines were collated, using systematic searches, and appraised.
A total of 59 papers were reviewed. Familiarity and trust in brand names appears to be a substantial barrier to the increased use of generics, with patients also appearing to hold the view that if a product is cheaper, then it must not be as good. Some publications report positive views of generics, with positively inclined consumers stating that they did not perceive any difference between a generic and the proprietary medicine. Acceptance of generics appears to be higher in consumers with higher levels of education while patients from lower socioeconomic demographic groups tend to have greater mistrust of generics.
The provision of information to consumers that dispels myths about generics may improve confidence in generic medicines. As patients demonstrate a high degree of trust in physicians, their opinions can impact on patient/consumer opinions. Therefore, enhancing the perceptions of generics held by physicians is likely to have a positive impact on patient/consumer opinions of, and trust in, generic medications.
KeywordsGeneric Medication Generic Medicine Generic Drug MeSH Term Generic Substitution
Compliance with Ethical Standards
The author declares that there is no conflict of interest. No funding was received to perform this study.
- 1.World Health Organisation. Generic drugs. Available from http://www.who.int/trade/glossary/story034/en/index.html. Accessed 26 Apr 2016.
- 2.European Medicines Agency. EMA Q&A on generic medicine. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf. Accessed 26 Apr 2016.
- 3.Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013;14(1):1.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.World Health Organisation. WHO drug information volume 28, No. 1, 2014. Available from: http://www.who.int/medicines/publications/druginformation/issues/DrugInformation2014_Vol28-1/en/. Accessed 21 June 2015.
- 5.OECD. What Future for Health Spending? In: OECD Economics Department policy notes, No. 19. . 2013. Available from: http://www.oecd.org/economy/health-spending.pdf. Accessed 21 June 2015.
- 7.Al Ameri MN, Mohamed W, Makramalla E, Shalhoub B, Tucker A, Johnston A. Renal patients’ views on generic prescribing and substitution: example from the United Arab Emirates. Eastern Med Health J. 2013;19(4):373–81.Google Scholar
- 15.Choudhry NK, Cox E, Fischer MA, Mehta J, Shrank WH. Setting prices for generic medications: a survey of patients perceptions. Am J Pharm Benefits. 2010;2(1):33–8.Google Scholar
- 29.Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6.Google Scholar
- 36.Jacomet C, Allavena C, Peyrol F, Pereira B, Joubert LM, Bagheri H, et al. Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France. PloS One. 2015;10(2):e0117214. doi: 10.1371/journal.pone.0117214.CrossRefPubMedPubMedCentralGoogle Scholar
- 42.McAuley JW, Chen AY, Elliott JO, Shneker BF. An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy. Epilepsy Behav. 2009;14(1):113–7. doi: 10.1016/j.yebeh.2008.08.009.CrossRefPubMedGoogle Scholar
- 53.Rathe J, Andersen M, Jarbol DE, dePont Christensen R, Hallas J, Sondergaard J. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study. PloS One. 2015;10(3):e0119688. doi: 10.1371/journal.pone.0119688.CrossRefPubMedPubMedCentralGoogle Scholar
- 66.Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AH, Aljadhey H. Patients’ beliefs about generic medicines in Malaysia. Pharm Pract. 2014;12(4):474.Google Scholar
- 67.International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2015. Available from: http://www.icmje.org/icmje-recommendations.pdf. Accessed 15 Jan 2016.
- 68.Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514–26. doi: 10.1001/jama.2008.758.CrossRefPubMedPubMedCentralGoogle Scholar
- 69.US FDA. Review of therapeutic equivalence generic Bupropion XL 300 mg and Wellbutrin XL 300 mg. FDA, FDA website. 2013. Available from: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm153270.htm. Accessed 22 Nov 2014.
- 70.US FDA. Methylphenidate hydrochloride extended release tablets (generic Concerta) made by Mallinckrodt and Kudco. FDA, FDA website. 2015. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm422568.htm. Accessed 22 Nov 2014.
- 72.US FDA. Size, shape, and other physical attributes of generic tablets and capsules: guidance for Industry. US FDA. 2015. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm377938.pdf. Accessed 15 Jan 2016.